Literature DB >> 28416489

NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.

Kevin Lu1, Allen L Alcivar1, Jianglin Ma1, Tzeh Keong Foo1, Susan Zywea1, Amar Mahdi1, Yanying Huo1, Thomas W Kensler2, Michael L Gatza1, Bing Xia3.   

Abstract

NRF2 is a transcription factor serving as a master regulator of the expression of many genes involved in cellular responses to oxidative and other stresses. In the absence of stress, NRF2 is constantly synthesized but maintained at low levels as it is targeted by KEAP1 for ubiquitination and proteasome-mediated degradation. NRF2 binds KEAP1 mainly through a conserved "ETGE" motif that has also been found in several other proteins, such as DPP3, which has been shown to bind KEAP1 and enhance NRF2 function upon overexpression. Here we demonstrate the interaction between endogenous DPP3 and endogenous KEAP1. We further show that the DPP3-KEAP1 interaction is strongly induced by hydrogen peroxide and that DPP3 is required for timely NRF2 induction and nuclear accumulation in the estrogen receptor (ER)-positive MCF7 breast cancer cells. Moreover, we present evidence that the binding of DPP3 to KEAP1 stabilizes the latter. Finally, we show that DPP3 is overexpressed in breast cancer and that elevated levels of DPP3 mRNA correlate with increased NRF2 downstream gene expression and poor prognosis, particularly for ER-positive breast cancer. Our studies reveal novel insights into the regulation of NRF2 and identify DPP3 and an NRF2 transcriptional signature as potential biomarkers for breast cancer prognosis and treatment. Cancer Res; 77(11); 2881-92. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28416489      PMCID: PMC5464605          DOI: 10.1158/0008-5472.CAN-16-2204

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.

Authors:  Alexandria Lau; Xiao-Jun Wang; Fei Zhao; Nicole F Villeneuve; Tongde Wu; Tao Jiang; Zheng Sun; Eileen White; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 3.  Role of nrf2 in oxidative stress and toxicity.

Authors:  Qiang Ma
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

Review 4.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.

Authors:  Keiko Taguchi; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2011-02       Impact factor: 1.891

Review 5.  Molecular basis of the Keap1-Nrf2 system.

Authors:  Takafumi Suzuki; Masayuki Yamamoto
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

6.  Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.

Authors:  Bridgid E Hast; Dennis Goldfarb; Kathleen M Mulvaney; Michael A Hast; Priscila F Siesser; Feng Yan; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

7.  Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway.

Authors:  Ian M Copple; Adam Lister; Akua D Obeng; Neil R Kitteringham; Rosalind E Jenkins; Robert Layfield; Brian J Foster; Christopher E Goldring; B Kevin Park
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

8.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

9.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

10.  Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex.

Authors:  Liam Baird; David Llères; Sam Swift; Albena T Dinkova-Kostova
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-28       Impact factor: 11.205

View more
  40 in total

Review 1.  The Role of Nrf2 in the Response to Normal Tissue Radiation Injury.

Authors:  Brent D Cameron; Konjeti R Sekhar; Maxwell Ofori; Michael L Freeman
Journal:  Radiat Res       Date:  2018-05-25       Impact factor: 2.841

2.  Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.

Authors:  Ciro Menale; Lisa J Robinson; Eleonora Palagano; Rosita Rigoni; Marco Erreni; Alejandro J Almarza; Dario Strina; Stefano Mantero; Michela Lizier; Antonella Forlino; Roberta Besio; Marta Monari; Paolo Vezzoni; Barbara Cassani; Harry C Blair; Anna Villa; Cristina Sobacchi
Journal:  J Bone Miner Res       Date:  2019-09-09       Impact factor: 6.741

Review 3.  Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.

Authors:  L K Kadian; M Arora; C P Prasad; R Pramanik; S S Chauhan
Journal:  Clin Transl Oncol       Date:  2022-01-06       Impact factor: 3.405

4.  Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women.

Authors:  Ciro Menale; Gaia Tabacco; Anda Mihaela Naciu; Maria Lucia Schiavone; Francesca Cannata; Emanuela Morenghi; Cristina Sobacchi; Andrea Palermo
Journal:  Molecules       Date:  2022-06-19       Impact factor: 4.927

5.  Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer.

Authors:  Xinghan Wu; Huan Sheng; Liping Zhao; Mingxia Jiang; Han Lou; Yue Miao; Ni Cheng; Weifen Zhang; Dejun Ding; Wentong Li
Journal:  Cell Death Dis       Date:  2022-06-20       Impact factor: 9.685

Review 6.  Beyond repression of Nrf2: An update on Keap1.

Authors:  Aleksandra Kopacz; Damian Kloska; Henry Jay Forman; Alicja Jozkowicz; Anna Grochot-Przeczek
Journal:  Free Radic Biol Med       Date:  2020-03-28       Impact factor: 7.376

Review 7.  The intricacies of NRF2 regulation in cancer.

Authors:  Cody J Schmidlin; Aryatara Shakya; Matthew Dodson; Eli Chapman; Donna D Zhang
Journal:  Semin Cancer Biol       Date:  2021-05-18       Impact factor: 15.707

8.  CEMIP promotes extracellular matrix-detached prostate cancer cell survival by inhibiting ferroptosis.

Authors:  Bing Liu; Xuexiang Li; Decai Wang; Ying Yu; Dingheng Lu; Liang Chen; Fang Lv; Yunxue Li; Lulin Cheng; Yarong Song; Yifei Xing
Journal:  Cancer Sci       Date:  2022-04-15       Impact factor: 6.518

9.  miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway.

Authors:  Ying Miao; Qin Wan; Xiaoyu Liu; Yu Wang; Yi Luo; Dan Liu; Nengbo Lin; Honggang Zhou; Jiyuan Zhong
Journal:  Biomed Res Int       Date:  2017-12-18       Impact factor: 3.411

10.  Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome.

Authors:  Adrián Benito; Ibrahim H Polat; Véronique Noé; Carlos J Ciudad; Silvia Marin; Marta Cascante
Journal:  Oncotarget       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.